The Therapeutic Effectiveness of Laparoscopic Sleeve Gastrectomy Among Individuals with Low BMI Obesity (30-35 Kg/m2) and the Relationship of BMI to Weight Loss
DOI: https://doi.org/10.2147/ijgm.s454052
IF: 2.145
2024-04-23
International Journal of General Medicine
Abstract:Zilong Yue, 1, 2, &ast Yan Jin, 1, 3, &ast Hui Sha, 1, &ast Qin Wu, 1, &ast Lele Li, 1 Yabin Xia, 1 Kaifeng Hu 1 1 Department of Gastrointestinal Surgery, The First Affiliated Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, People's Republic of China; 2 General Surgery Department, Guoyang Branch of Anhui Provincial Hospital, Bozhou, Anhui, People's Republic of China; 3 Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Kaifeng Hu, Department of Gastrointestinal Surgery, The First Affiliated Yijishan Hospital of Wannan Medical College, Wuhu, No. 2, Zheshan West Road, Anhui, 241001, People's Republic of China, Tel +86-13655537677, Email Purpose: Investigating the therapeutic efficacy of Laparoscopic Sleeve Gastrectomy (LSG) in low BMI (30– 35 kg/m 2 ) patients with obesity, and exploring the correlation between patients' preoperative BMI and postoperative weight loss. Methods: Comparing the weight loss, remission of comorbidities, occurrence of complications, and quality of life among the different BMI patients who underwent LSG. Analyzing the relationship between BMI and percentage of excess weight loss (%EWL) by using Spearman correlation analysis and linear regression analysis. Results: The %EWL at 12 months after the surgical procedure was (104.26± 16.41)%, (90.36± 9.98)%, and (78.30± 14.64)% for patients with Class I, II, and III obesity, respectively, P< 0.05. Spearman correlation coefficients between %EWL and BMI at 1, 3, 6, and 12 months after surgery were R=− 0.334 (P< 0.001), R=− 0.389 (P< 0.001), and R=− 0.442 (P< 0.001), R=− 0.641 (P 0.05). Conclusion: Individuals with obesity for varying BMI can experience favorable outcomes following LSG surgery. It is advisable to consider LSG treatment for patients with Class I obesity. Keywords: laparoscopic sleeve gastrectomy, body mass index, percentage of excess weight loss Obesity presents a significant global challenge, characterized as a complex chronic condition resulting from abnormal or excessive fat accumulation. 1,2 By the year 2015, the global population witnessed an approximate count of 107.7 million children and 603.7 million adults who were afflicted by obesity. 3 Obesity is strongly associated with the onset and progression of numerous illnesses, 4–8 and it has become a serious threat to the health and lives of people in every country, imposing a substantial strain on public health systems across nations. Bariatric surgery frequently yields more favorable outcomes in addressing morbid obesity compared to conventional weight reduction approaches. According to a 2018 survey conducted by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) across five branches worldwide, LSG is currently the most used form of bariatric surgery in the world, accounting for 55.4% of all bariatric procedures. 9 As the amount of LSG continues to increase, the suitability of patients with mild obesity for LSG treatment has become a major concern for bariatric surgeons. In 1991, the patients with obesity of BMI ≥ 35 kg/m 2 as a criterion for bariatric surgery. 10 But in 2022, the criterion for bariatric surgery suggested revising the indication for to BMI >27.5 kg/m2 in Asian populations. 11 Differences in fat distribution, hormone regulation, nutrient absorption, and metabolism in individuals with obesity of various BMI, 12,13 which are associated with LSG efficacy. 14 More evidence is therefore needed to support the suitability of patients with low BMI for LSG treatment. The research conducted by Uri Kaplan demonstrated that patient's preoperative BMI was an independent influence on postoperative weight change. 15 Based on this premise, this study aimed to analyze patients with obesity treated with LSG in our center, to examine the effectiveness and safety of LSG in individuals with obesity who have varying BMI and the effectiveness of LSG as a treatment option for patients with a low BMI, to provide some help for future clinical work. This retrospective study was conducted at the Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wannan Medical College. Patients who underwent LSG at our center from October 1, 2019, to May -Abstract Truncated-
medicine, general & internal